106 related articles for article (PubMed ID: 20225234)
1. Differential antiapoptotic effect of erythropoietin on undifferentiated and retinoic acid-differentiated SH-SY5Y cells.
Wenker SD; Chamorro ME; Vota DM; Callero MA; Vittori DC; Nesse AB
J Cell Biochem; 2010 May; 110(1):151-61. PubMed ID: 20225234
[TBL] [Abstract][Full Text] [Related]
2. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells.
Pregi N; Wenker S; Vittori D; Leirós CP; Nesse A
Exp Cell Res; 2009 Feb; 315(3):419-31. PubMed ID: 19056379
[TBL] [Abstract][Full Text] [Related]
4. c-FLIP is involved in erythropoietin-mediated protection of erythroid-differentiated cells from TNF-alpha-induced apoptosis.
Vittori D; Vota D; Callero M; Chamorro ME; Nesse A
Cell Biol Int; 2010 May; 34(6):621-30. PubMed ID: 20218968
[TBL] [Abstract][Full Text] [Related]
5. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
Tieu K; Zuo DM; Yu PH
J Neurosci Res; 1999 Nov; 58(3):426-35. PubMed ID: 10518116
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
[TBL] [Abstract][Full Text] [Related]
8. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
9. Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells.
Pan J; Kao YL; Joshi S; Jeetendran S; Dipette D; Singh US
J Neurochem; 2005 May; 93(3):571-83. PubMed ID: 15836616
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
[TBL] [Abstract][Full Text] [Related]
11. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells.
Sumantran VN; Brederlau A; Funa K
Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
13. Isoflurane attenuates dynorphin-induced cytotoxicity and downregulation of Bcl-2 expression in differentiated neuroblastoma SH-SY5Y cells.
Wu GJ; Chen WF; Sung CS; Jean YH; Hung CH; Chen FA; Hsieh MH; Wen ZH
Acta Anaesthesiol Scand; 2009 Jan; 53(1):55-60. PubMed ID: 19032555
[TBL] [Abstract][Full Text] [Related]
14. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Feb; 432(2):146-50. PubMed ID: 18201823
[TBL] [Abstract][Full Text] [Related]
15. Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2.
Tsushima H; Urata Y; Miyazaki Y; Fuchigami K; Kuriyama K; Kondo T; Tomonaga M
Cell Growth Differ; 1997 Dec; 8(12):1317-28. PubMed ID: 9419420
[TBL] [Abstract][Full Text] [Related]
16. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of polysialylated neural cell adhesion molecule expression by NMDA receptor activation in retinoic acid-differentiated SH-SY5Y neuroblastoma cultures.
Singh J; Kaur G
Brain Res; 2007 Jun; 1154():8-21. PubMed ID: 17499225
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma.
Niizuma H; Nakamura Y; Ozaki T; Nakanishi H; Ohira M; Isogai E; Kageyama H; Imaizumi M; Nakagawara A
Oncogene; 2006 Aug; 25(36):5046-55. PubMed ID: 16568081
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
20. Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells.
Tanaka K; Tamiya-Koizumi K; Hagiwara K; Ito H; Takagi A; Kojima T; Suzuki M; Iwaki S; Fujii S; Nakamura M; Banno Y; Kannagi R; Tsurumi T; Kyogashima M; Murate T
J Biochem; 2012 Jun; 151(6):611-20. PubMed ID: 22451680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
